We are your partner in biosimilars and breakthrough therapies. With our support, you can ensure your patients benefit from the latest advances in this field while at the same time keeping healthcare costs under control.
Researchers, manufacturers and investors
We are always on the lookout for promising new molecules. With our in-house medical expertise and extensive local contacts, we can onboard new products quickly and efficiently, and facilitate sales and distribution in Switzerland and other European countries.
With opportunity comes responsibility. iQone was founded in 2013 by a handful of experts from leading pharmaceutical companies who recognized the disruptive potential of biosimilars. They came up with an agile model to promote these and other life-changing drugs in Switzerland, serving as the crucial link between global manufacturers and local healthcare professionals. iQone's unique combination of social responsibility, expertise and personalized service helps to improve the lives of countless patients.
Products and pipeline
iQone has one of the most complete biosimilar portfolios in Switzerland and we are steadily diversifying with innovative new drugs. We specialize in oncology and immunology in general, with a particular focus on rheumatology, gastro-enterology and onco-haematology, yet we are poised to expand into other disease areas. We source our products from leading developers of pharmaceuticals and biologics around the world.
Our services for healthcare professionals
Stocks and delivery
We maintain ample stocks and deliver anywhere in Switzerland (and potentially beyond) within 24 hours, and we back this up with tailored pre- and post-sales service.
We provide healthcare professionals with full medical information and training on every product. Our experts will respond quickly to your requests for additional support.
We use data matrices to ensure full traceability, making it easy for you to manage your own stocks and identify our products quickly and accurately.